The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment.

Belinda M. Kumpel(NHS Blood and Transplant), G.A.W. Rook(Dementia UK), Andrew G. Hadley, Helen Griffiths, Yan Wang(Jiangsu Provincial Center for Disease Control and Prevention)

PubMed

January 1, 1995

Cited by 71

Related Papers

The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems

|The Science of The Total Environment|2018|394

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health

|Current Environmental Health Reports|2016|174

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103